Seeking Alpha

Amarin (AMRN +1.85%) says the Patent Office has published a notification of a Notice of...

Amarin (AMRN +1.85%) says the Patent Office has published a notification of a Notice of Allowance for an application to widen the company's patent claims to include the use of its heart pill Vascepa with and without other lipid lowering agents, such as statins. A Notice of Allowance means the USPTO has decided that a patent can be granted from an application.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|